midazolam and emd1214063

midazolam has been researched along with emd1214063 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Bachmann, A; Becker, A; Biedert, H; Bytyqi, A; Heuer, J; Hirt, S; Krebs-Brown, A; Lüpfert, C; Perrin, D; Strotmann, R; Vetter, C; Yalkinoglu, Ö	1

Other Studies

1 other study(ies) available for midazolam and emd1214063

Article	Year
Assessment of the potential of the MET inhibitor tepotinib to affect the pharmacokinetics of CYP3A4 and P-gp substrates. Investigational new drugs, 2023, Volume: 41, Issue:4 Topics: ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caco-2 Cells; Carcinoma, Non-Small-Cell Lung; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dabigatran; Drug Interactions; Humans; Lung Neoplasms; Midazolam	2023

Article

Year

Assessment of the potential of the MET inhibitor tepotinib to affect the pharmacokinetics of CYP3A4 and P-gp substrates.

Investigational new drugs, 2023, Volume: 41, Issue:4

Topics: ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caco-2 Cells; Carcinoma, Non-Small-Cell Lung; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dabigatran; Drug Interactions; Humans; Lung Neoplasms; Midazolam

2023